查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1701250

美国病人参与解决方案市场规模、份额、趋势分析报告：按类型、产品类型、功能、最终用途、国家/地区、细分预测，2025 年至 2030 年

U.S. Patient Engagement Solutions Market Size, Share & Trends Analysis Report By Type, By Delivery Type, By Functionality, By End Use, By Country, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 149 Pages | 商品交期: 2-10个工作天内

价格

美国病人参与解决方案市场成长与趋势：

根据Grand View Research, Inc.的最新报告，美国病人参与解决方案市场规模预计到2030年将达到224.1亿美元，2025年至2030年期间的复合年增长率为19.77%。

推动市场成长的关键因素包括医疗保健数位化的提高、慢性病的流行、患者的接受度以及 COVID-19 大流行。

新冠疫情成为商业和经济快速变革的催化剂。某些在过去几十年中稳步增长的趋势，例如数位医疗解决方案，由于封锁要求远端工作和对技术的大量依赖，已出乎意料地变得无处不在。此外，COVID-19 疫情表明，临床医生快速、完整地了解患者的病历对于就患者的护理做出最佳明智决策至关重要。这促进了市场的成长。

例如，2020 年 2 月，SolutionReach 宣布推出 SR Health，这是一个针对医院、健康系统和企业医疗保健组织的基于人工智慧的病人参与平台。随后，该公司于 2021 年 1 月增加了疫苗分发通讯，作为其 COVID-19 通讯解决方案的一部分。 60岁以上人口众多是美国病人参与解决方案市场的主要动力。这是因为老年人的免疫力水平较低，更容易患肥胖症、心臟病和癌症等慢性疾病。

事实上，根据美国人口普查局的数据，到 2060 年，美国人口中位数预计将达到 43 岁，这意味着每 2.5 名工作年龄成年人对应一名退休人员。这表明，随着美国老化，人们更有可能接受最好的治疗以延长寿命。儘管美国治疗方法，但慢性病的盛行率仍在上升。儘管美国治疗方法，但慢性病的发生率也在上升。

据美国疾病管制与预防中心称，慢性病是导致残疾和死亡的主要原因，也是美国12 个月医疗保健费用高达 3.8 兆美元的主要原因。 COVID-19 疫情加速了对数位解决方案的需求，并凸显了远距医疗的必要性。行动平台的日益普及，加上不间断的 3G、4G 网路和新兴 5G 技术的广泛普及，正在迅速推动行动医疗的使用。

此外，美国医生使用行动电话和网路的人数也​​出现了惊人的成长，从而推动了行动医疗解决方案的发展。事实证明，使用行动应用程式在传播慢性病知识、管理个人健康、与医疗保健提供者沟通、管理健康记录等方面非常有效。预计这将推动市场成长。

美国病人参与解决方案市场报告重点

  • 在人工智慧、机器学习和远端医疗的推动下，美国市场经历了高水准的创新。例如，2024 年 8 月，医疗保健体验测量和资料分析提供者 Press Ganey 宣布扩展其 PX Connect Suite，使医疗保健组织能够直接在 Epic 中捕获患者反馈并采取行动。
  • 预计人工智慧主导的参与部分将在 2024 年占据最大的收入份额，达到 30.54%，并以最快的复合年增长率扩张，这得益于其个性化护理和增强患者与提供者之间互动的能力。
  • 预计到 2024 年，云端基础的领域将占据市场主导地位，收益占有率将达到 67.38%，并且预计将以最快的复合年增长率扩张。造成这种情况的因素包括远端医疗的日益普及、对远端患者监护的需求不断增加以及向基于价值的照护模式的转变。
  • 2024 年，通讯增强部分占据了最大的收益占有率。医疗保健领域越来越多地采用人工智慧主导的解决方案，这推动了对先进通讯功能的需求。
  • 医疗保健提供者部门在 2024 年占据了最大的收益占有率。医疗保健提供者治疗的患者数量最多，并且是从一般护理到专科护理等各种健康问题的主要接触点，这使他们成为病人参与解决方案的领先采用者。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场趋势与展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 案例研究
  • 法律规范
    • 产业分析－波特五力分析：製药业
    • 波特五力分析
    • 依因素（政治/法律、经济、社会、技术）进行 PEST 分析
    • COVID-19影响分析

第四章美国病人参与解决方案市场：类型估计和趋势分析

  • 美国病人参与解决方案市场：类型变化分析
  • 美国病人参与解决方案市场：类型细分仪表板
  • 2024 年和 2030 年类型趋势和市场占有率分析
  • 按类型
  • 人工智慧驱动的参与
  • 远端医疗解决方案
  • 患者门户网站
  • 远端患者监护
  • 人口健康管理
  • 预约和药物提醒
  • 其他的

第五章。美国病人参与解决方案市场：按产品类型和趋势分析进行估计

  • 美国病人参与解决方案市场：产品类型变化分析
  • 美国病人参与解决方案市场：产品类型细分仪表板
  • 2024 年和 2030 年产品类型趋势和市场占有率分析
  • 依产品类型
  • 云端基础
  • 本地

第六章美国病人参与解决方案市场：能力评估与趋势分析

  • 美国病人参与解决方案市场：功能变异分析
  • 美国病人参与解决方案市场：功能性细分仪表板
  • 2024 年和 2030 年功能趋势和市场占有率分析
  • 按功能
  • 增强沟通
  • 病患教育
  • 预测分析
  • 精简营运
  • 其他的

第七章美国病人参与解决方案市场：最终用途估计与趋势分析

  • 美国病人参与解决方案市场：最终用途差异分析
  • 美国病人参与解决方案市场：最终用途细分仪表板
  • 2024 年和 2030 年最终用途趋势和市场占有率分析
  • 按最终用途
  • 医疗保健提供者
    • 门诊设施
    • 住院设施
  • 医疗保健付款人
    • 私人的
    • 公共
  • 製药公司
  • 药局
    • 独立药房（经认证的核子医学药房）
    • 当地药房
    • 通讯药房
    • 零售药局
    • 数位药房
    • 专业药房
    • 中央填充药房
    • 配药房
    • 其他（替代配药地点、封闭设施）

第八章竞争格局

  • 公司分类
  • 企业市场分析
  • 企业市场占有率分析
    • 伙伴关係/合作/联盟
    • 推出新服务
    • 合併与收购
    • 其他的
  • 公司简介/列表
    • Cerner Corporation（Oracle）
    • NextGen Healthcare, Inc.
    • Epic Systems Corporation
    • Allscripts Healthcare, LLC
    • McKesson Corporation
    • ResMed
    • Koninklijke Philips NV
    • Klara Technologies, Inc.
    • CPSI, Ltd.
    • Experian Information Solutions, Inc.
    • athenahealth
    • Solutionreach, Inc.
    • IBM
    • MEDHOST
    • Nuance Communications, Inc.
Product Code: GVR-2-68038-427-7

U.S. Patient Engagement Solutions Market Growth & Trends:

The U.S. patient engagement solutions market size is anticipated to reach USD 22.41 billion in 2030 and is expected to grow at a CAGR of 19.77% from 2025 to 2030, according to a new report by Grand View Research, Inc. The key factors driving the market growth include rising digitalization in healthcare, the prevalence of chronic conditions, adoption by patients, and the COVID-19 pandemic.

The COVID-19 pandemic acted as a catalyst for rapid business and economic changes. Certain trends, which grew steadily in the past decades, including digital healthcare solutions, unexpectedly became omnipresent as lockdowns directed remote operations and large-scale reliance on technology. In addition, the COVID-19 pandemic has shown the importance for clinicians to have rapid and full access to a patient's history to make the best-informed decision about their care. This propelled the growth of the market.

For instance, in February 2020, Solutionreach, Inc. launched SR Health, an AI-based patient engagement platform for hospitals, health systems, and enterprise healthcare organizations. This was followed by the addition of vaccine distribution messaging as part of its SR Health COVID-19 Communications solution, in January 2021. A large population over the age of 60 is a key driver for the U.S. patient engagement solutions market. This is owing to lower immunity levels in the geriatric population and higher vulnerability to chronic conditions such as obesity, cardiac problems, and cancer.

In fact, as per the U.S. Census Bureau, the median age of the country's population is estimated to reach age 43 by 2060 with just two-and-a-half working-age adults for every retirement-age individual. This indicates an aging U.S. population that is more likely to avail the best possible treatments to increase life span. The incidence of chronic illnesses in the U.S. is also on the rise despite the availability of several effective therapies. The incidence of chronic illnesses in the U.S. is also on the rise despite the availability of several effective therapies.

Chronic ailments are the leading cause of disability & death and are the leading drivers of the country's USD 3.8 trillion 12-monthly healthcare costs, according to the CDC. The COVID-19 outbreak has expedited the necessity for digital solutions, highlighting the need for remote care, which is not only preferred but also essential. Increasing adoption of mobile platforms coupled with the dissemination of uninterrupted 3G, 4G networks, and emerging 5G technology, are rapidly boosting the use of mobile health.

Furthermore, there has been an incredible upsurge in the use of mobile phones and the internet by physicians in the U.S. leading to the progress of mobile health solutions. The usage of mobile applications has proven to be very effective in spreading awareness about chronic diseases, managing personal health, communicating with healthcare providers, and maintaining health records. This is expected to fuel the market growth.

U.S. Patient Engagement Solutions Market Report Highlights:

  • The U.S. market experienced high levels of innovation, driven by advancements in AI, machine learning, and telemedicine. For instance, in August 2024, Press Ganey, a healthcare provider of experience measurement and data analytics, announced an expansion of its PX Connect Suite, allowing healthcare organizations to capture and respond to patient feedback directly within Epic
  • The AI-driven engagement segment held the largest revenue share of 30.54% in 2024 and is anticipated to expand at the fastest CAGR due to its ability to personalize care and enhance patient-provider interactions
  • The web/cloud-based segment dominated the market in 2024 with a revenue share of 67.38% and is anticipated to expand at the fastest CAGR. Factors include the growing adoption of telehealth, increased demand for remote patient monitoring, and the shift to value-based care models
  • The enhanced communication segment held the largest revenue share in 2024. With the increasing adoption of AI-driven solutions in healthcare, the demand for advanced communication capabilities is growing
  • The healthcare providers segment held the largest revenue share in 2024. Providers handle the highest number of patients and serve as the main point of contact for a wide range of health issues, from general to specialized care, and are the primary adopters of patient engagement solutions

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
    • 1.4.6. Research Assumption
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Data Visualization
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. Objectives
    • 1.8.1. Objective - 1
    • 1.8.2. Objective - 2
    • 1.8.3. Objective - 3
  • 1.9. List of Secondary Sources
  • 1.10. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. U.S. Patient Engagement Solutions Market
    • 2.1.1. Market Snapshot
    • 2.1.2. Segment Snapshot
      • 2.1.2.1. Types segment outlook
      • 2.1.2.2. Delivery type segment outlook
      • 2.1.2.3. Functionality segment outlook
      • 2.1.2.4. End Use segment outlook
    • 2.1.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Shift toward patient-centered care
      • 3.3.1.2. Growing need to curb rising healthcare costs
      • 3.3.1.3. Rising initiatives by organizations
      • 3.3.1.4. The emergence of digital platforms and necessity for omnichannel approach
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Data privacy and ethical considerations
      • 3.3.2.2. Lack of Interoperability Among Healthcare Providers
    • 3.3.3. Market Opportunity Analysis
    • 3.3.4. Market Challenges Analysis
  • 3.4. Case Studies
  • 3.5. Regulatory Framework
    • 3.5.1. Industry Analysis - Porter's Five Forces Analysis:- Pharmacy
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. Porter's five forces analysis
    • 3.5.3. PEST Analysis by Factors (Political & Legal, Economic, Social, and Technology)
    • 3.5.4. COVID-19 Impact Analysis

Chapter 4. U.S. Patient Engagement Solutions Market: Type Estimates & Trend Analysis

  • 4.1. U.S. Patient Engagement Solutions Market: Type Movement Analysis
  • 4.2. U.S. Patient Engagement Solutions Market: Type Segment Dashboard
  • 4.3. Type Movement & Market Share Analysis, 2024 & 2030
  • 4.4. U.S. Patient Engagement Solutions Market Estimates & Forecast, by Type
  • 4.5. AI-Driven Engagement
    • 4.5.1. AI-driven engagement market, 2018 - 2030 (USD Million)
  • 4.6. Telehealth Solutions
    • 4.6.1. Telehealth Solutions market, 2018 - 2030 (USD Million)
  • 4.7. Patient Portals
    • 4.7.1. Patient Portals market, 2018 - 2030 (USD Million)
  • 4.8. Remote Patient Monitoring
    • 4.8.1. Remote Patient Monitoring market, 2018 - 2030 (USD Million)
  • 4.9. Population Health Management
    • 4.9.1. Population Health Management market, 2018 - 2030 (USD Million)
  • 4.10. Appointment and Medication Reminders
    • 4.10.1. Appointment and Medication Reminders market, 2018 - 2030 (USD Million)
  • 4.11. Others
    • 4.11.1. Others market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Patient Engagement Solutions Market: Delivery Type Estimates & Trend Analysis

  • 5.1. U.S. Patient Engagement Solutions Market: Delivery Type Movement Analysis
  • 5.2. U.S. Patient Engagement Solutions Market: Delivery Type Segment Dashboard
  • 5.3. Delivery Type Movement & Market Share Analysis, 2024 & 2030
  • 5.4. U.S. Patient Engagement Solutions Market Estimates & Forecast, by Delivery Type
  • 5.5. Web/Cloud-Based
    • 5.5.1. Web/cloud-based market, 2018 - 2030 (USD Million)
  • 5.6. On-premise
    • 5.6.1. On-premise market, 2018 - 2030 (USD Million)

Chapter 6. U.S. Patient Engagement Solutions Market: Functionality Estimates & Trend Analysis

  • 6.1. U.S. Patient Engagement Solutions Market: Functionality Movement Analysis
  • 6.2. U.S. Patient Engagement Solutions Market: Functionality Segment Dashboard
  • 6.3. Functionality Movement & Market Share Analysis, 2024 & 2030
  • 6.4. U.S. Patient Engagement Solutions Market Estimates & Forecast, by Functionality
  • 6.5. Enhanced Communication
    • 6.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 6.6. Patient Education
    • 6.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 6.7. Predictive Analysis
    • 6.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 6.8. Streamlined Operations
    • 6.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)

Chapter 7. U.S. Patient Engagement Solutions Market: End Use Estimates & Trend Analysis

  • 7.1. U.S. Patient Engagement Solutions Market: End Use Movement Analysis
  • 7.2. U.S. Patient Engagement Solutions Market: End Use Segment Dashboard
  • 7.3. End Use Movement & Market Share Analysis, 2024 & 2030
  • 7.4. U.S. Patient Engagement Solutions Market Estimates & Forecast, by End Use
  • 7.5. Healthcare Providers
    • 7.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.5.2. Outpatient Facility
      • 7.5.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.5.3. Inpatient Facility
      • 7.5.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.6. Healthcare Payers
    • 7.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.6.2. Private
      • 7.6.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.6.3. Public
      • 7.6.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.7. Pharmaceutical Companies (Pharma)
    • 7.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 7.8. Pharmacy
    • 7.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.2. Independent Pharmacies (Nuclear Pharmacies)
      • 7.8.2.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.3. Community Pharmacies
      • 7.8.3.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.4. Mail-Order Pharmacies
      • 7.8.4.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.5. Retail Pharmacies
      • 7.8.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.6. Digital Pharmacies
      • 7.8.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.7. Specialty Pharmacies
      • 7.8.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.8. Central Fill Pharmacies
      • 7.8.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.9. Compounding Pharmacies
      • 7.8.9.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
    • 7.8.10. Others (Alternate dispensing site, Closed door)
      • 7.8.10.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Company Market Position Analysis
  • 8.3. Company Share Analysis
    • 8.3.1. Partnership/Collaboration/Alliance
    • 8.3.2. New Service Launch
    • 8.3.3. Mergers & Acquisitions
    • 8.3.4. Others
  • 8.4. Company Profiles/Listing
    • 8.4.1. Cerner Corporation (Oracle)
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Service benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. NextGen Healthcare, Inc.
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Service benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Epic Systems Corporation
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Service benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Allscripts Healthcare, LLC
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Service benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. McKesson Corporation
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Service benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. ResMed
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Service benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Koninklijke Philips N.V.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Service benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Klara Technologies, Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Service benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. CPSI, Ltd.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Service benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Experian Information Solutions, Inc.
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Service benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. athenahealth
      • 8.4.11.1. Overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Service benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Solutionreach, Inc.
      • 8.4.12.1. Overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Service benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. IBM
      • 8.4.13.1. Overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Service benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. MEDHOST
      • 8.4.14.1. Overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Service benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. Nuance Communications, Inc.
      • 8.4.15.1. Overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Service benchmarking
      • 8.4.15.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. patient engagement solutions market revenue estimates and forecast, by types, 2018 - 2030 (USD Million)
  • Table 4 U.S. patient engagement solutions market revenue estimates and forecast, by delivery type, 2018 - 2030 (USD Million)
  • Table 5 U.S. patient engagement solutions market revenue estimates and forecast, by functionality, 2018 - 2030 (USD Million)
  • Table 6 U.S. patient engagement solutions market revenue estimates and forecast, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig 1. U.S. Patient Engagement Solutions Market Segmentation
  • Fig 2. Market research process
  • Fig 3. Information procurement
  • Fig 4. Primary research pattern
  • Fig 5. Market research approaches
  • Fig 6. Value chain based sizing & forecasting
  • Fig 7. QFD modelling for Market share assessment
  • Fig 8. Market formulation & validation
  • Fig 9. Market snapshot
  • Fig 10. Types segment outlook
  • Fig 11. Delivery Type segment outlook
  • Fig 12. Functionality segment outlook
  • Fig 13. End Use segment outlook
  • Fig 14. Competitive landscape
  • Fig 15. U.S. Patient Engagement Solutions Market: Market dynamics
  • Fig 16. U.S. Patient Engagement Solutions Market: Porter's analysis
  • Fig 17. U.S. Patient Engagement Solutions Market: PESTLE analysis
  • Fig 18. U.S. Patient Engagement Solutions Market: Types segment dashboard
  • Fig 19. U.S. Patient Engagement Solutions Market: Types movement share analysis
  • Fig 20. AI-Driven Engagement Market, 2018 - 2030 (USD Million)
  • Fig 21. Telehealth Solutions Market, 2018 - 2030 (USD Million)
  • Fig 22. Patient Portals Market, 2018 - 2030 (USD Million)
  • Fig 23. Remote Patient Monitoring Market, 2018 - 2030 (USD Million)
  • Fig 24. Population Health Management Market, 2018 - 2030 (USD Million)
  • Fig 25. Appointment and Medication Reminders Market, 2018 - 2030 (USD Million)
  • Fig 26. Others Market, 2018 - 2030 (USD Million)
  • Fig 27. U.S. Patient Engagement Solutions Market: Delivery Type segment dashboard
  • Fig 28. U.S. Patient Engagement Solutions Market: Delivery Type Movement Share Analysis
  • Fig 29. Web/Cloud-Based Market, 2018 - 2030 (USD Million)
  • Fig 30. On-premise Market, 2018 - 2030 (USD Million)
  • Fig 31. U.S. Patient Engagement Solutions Market: Functionality segment dashboard
  • Fig 32. U.S. Patient Engagement Solutions Market: Functionality Movement Share Analysis
  • Fig 33. Enhanced Communication Market, 2018 - 2030 (USD Million)
  • Fig 34. Patient Education Market, 2018 - 2030 (USD Million)
  • Fig 35. Predictive Analytics Market, 2018 - 2030 (USD Million)
  • Fig 36. Streamlined Operations Market, 2018 - 2030 (USD Million)
  • Fig 37. Others Market, 2018 - 2030 (USD Million)
  • Fig 38. U.S. Patient Engagement Solutions Market: End Use Segment Dashboard
  • Fig 39. U.S. Patient Engagement Solutions Market: End Use Movement Share Analysis
  • Fig 40. Healthcare Providers Market, 2018 - 2030 (USD Million)
  • Fig 41. Outpatient Facility Market, 2018 - 2030 (USD Million)
  • Fig 42. Inpatient Facility Market, 2018 - 2030 (USD Million)
  • Fig 43. Healthcare Payers Market, 2018 - 2030 (USD Million)
  • Fig 44. Private Market, 2018 - 2030 (USD Million)
  • Fig 45. Public Market, 2018 - 2030 (USD Million)
  • Fig 46. Pharmaceutical Companies (Pharma) Market, 2018 - 2030 (USD Million)
  • Fig 47. Pharmacy Market, 2018 - 2030 (USD Million) Market, 2018 - 2030 (USD Million)
  • Fig 48. Independent Pharmacies (Nuclear Pharmacies) Market, 2018 - 2030 (USD Million)
  • Fig 49. Community Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig 50. Mail-Order Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig 51. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig 52. Digital Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig 53. Specialty Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig 54. Central Fill Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig 55. Compounding Pharmacies Market, 2018 - 2030 (USD Million)
  • Fig 56. Others (Alternate dispensing site, Closed door) Market, 2018 - 2030 (USD Million)
  • Fig 57. Company categorization
  • Fig 58. Company Market position analysis
  • Fig 59. Strategic framework